BMEA
Biomea Fusion Inc
NASDAQ: BMEA · HEALTHCARE · BIOTECHNOLOGY
$1.36
-6.21% today
Updated 2026-04-30
Market cap
$136.65M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$1 – $3
Volume
1.5M
Biomea Fusion Inc (BMEA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — |
| Cost of revenue | — | $132000.00 | $953000.00 | $1.26M | $4.20M | $1.75M | $1.41M |
| Gross profit | — | $-132000.00 | $-953000.00 | $-1.26M | $-4.20M | $-1.75M | $-1.41M |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $1.09M | $3.67M | $28.00M | $62.71M | $102.55M | $118.08M | $61.98M |
| SG&A | $103000.00 | $1.66M | $13.67M | $20.92M | $23.59M | $25.98M | $19.33M |
| Operating income | $-1.20M | $-5.33M | $-41.67M | $-83.63M | $-126.14M | $-144.07M | $-81.31M |
| Operating margin | — | — | — | — | — | — | — |
| EBITDA | $-1.20M | $-5.19M | $-41.42M | $-82.94M | $-124.62M | $-142.32M | $-79.90M |
| EBITDA margin | — | — | — | — | — | — | — |
| EBIT | $-1.20M | $-5.32M | $-41.67M | $-83.63M | $-126.14M | $-144.07M | $-81.31M |
| Interest expense | $0.00 | $0.00 | $100000.00 | $1.81M | — | — | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.20M | $-5.32M | $-41.22M | $-80.02M | $-117.25M | $-138.43M | $-61.80M |
| Net income growth (YoY) | — | -344.4% | -674.2% | -94.1% | -46.5% | -18.1% | +55.4% |
| Profit margin | — | — | — | — | — | — | — |